-
Specialties
Board Certification
American Board of Obstetrics & GynecologyAmerican Board of Obstetrics & Gynecology (Sub: Gynecologic Oncology)Patient Rating
5.0 /5( out of 140 reviews )The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.
The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient Comments
Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.
October 28, 2025HUNTSMAN CANCER CENTERI really appreciated the time and kindness Dr. Maurer showed me. She took time to make sure I understood my condition and the procedure I would be needing.
October 24, 2025HUNTSMAN CANCER CENTERDr Maurer treated me with kindness and caring leaving me with a sense that my condition can be treated and I will be better
October 22, 2025HUNTSMAN CANCER CENTERDr. Maurer is knowledgeable, and attentive to the patient she is seeing.
October 20, 2025HUNTSMAN CANCER CENTERKathryn Maurer, MD is a very understanding and compassionate woman. I have always been treated with extreme care and concern at all of my visits with her.
August 26, 2025HUNTSMAN CANCER CENTERShe's an incredible doctor and I'm so grateful to have had her through my treatment!!!
August 26, 2025HUNTSMAN CANCER CENTERDr Mauer is awesome. She is brilliant and compassionate. She speaks directly to you and answers all your questions. She the best of the best.
May 07, 2025HUNTSMAN CANCER CENTERDr. Maurer is an extremely gifted surgeon. Not only is her technique outstanding, she is extremely knowledgeable and personable.
April 29, 2025HUNTSMAN CANCER CENTERHands-down, one of the best interactions with a doctor I've ever had. She's friendly, listens intently, thorough, and answers all questions. She cares about you as a person. She's a great surgeon.
April 24, 2025HUNTSMAN CANCER CENTERShe is awesome. I was and still am scard about cancer and what happens and she is not only brilliant but she explains all so well. I am so lucky I found her.
-
Board Certification and Academic Information
Academic Departments Obstetrics & Gynecology -Associate Professor (Clinical)
Academic Divisions Gynecological Oncology
Board Certification American Board of Obstetrics & GynecologyAmerican Board of Obstetrics & Gynecology (Sub: Gynecologic Oncology)Education history
Fellowship Gynecologic Oncology - Cleveland Clinic Fellow Residency Obstetrics and Gynecology - University of Utah School of Medicine Resident Professional Medical Medicine - University of Michigan Medical School M.D. Undergraduate Geology, Biology - Brown University Sc.B. Selected Publications
Journal Article
- Barnard ME, Farland LV, Yan B, Wang J, Trabert B, Doherty JA, Meeks HD, Madsen M, Guinto E, Collin LJ, Maurer KA, Page JM, Kiser AC, Varner MW, Allen-Brady K, Pollack AZ, Peterson KR, Peterson CM, Schliep KC (2025). Endometriosis Typology and Ovarian Cancer Risk. JAMA, 332(6), 482-489. ()
- Scaglione MA, Allshouse AA, Canfield DR, Mclaughlin HD, Bruno AM, Hammad IA, Branch DW, Maurer KA, Dood RL, Debbink MP, Silver RM, Einerson BD (2022). Prophylactic Ureteral Stent Placement and Urinary Injury During Hysterectomy for Placenta Accreta Spectrum. Obstet Gynecol, 140(5), 806-811. ()
- Straubhar AM, Parsons MW, Francis S, Gaffney D, Maurer KA (2021). Refusal of surgery and survival outcomes in endometrial cancer. Int J Gynecol Cancer, 31(9), 1236-1241. ()
- Casper AC, Parsons MW, Chipman J, Burt LM Jr, Suneja G, Maurer KA, Gaffney DK (2021). Risk of secondary malignancies in ovarian cancer survivors: 52,680 patients analyzed with over 40 years of follow-up. Gynecol Oncol, 162(2), 454-460. ()
- Parsons MW, Francis S, Maurer KA, Grant J, Gaffney DK (2020). Refusal of Radiation Results in Inferior Survival in Endometrial Cancer. Am J Clin Oncol, 43(6), 399-410. ()
- Harris KL, Maurer KA, Jarboe E, Werner TL, Gaffney D (2019). LVSI positive and NX in early endometrial cancer: Surgical restaging (and no further treatment if N0), or adjuvant ERT? Gynecol Oncol, 156(1), 243-250. ()
- McComas KN, Torgeson AM, Ager BJ, Hellekson C, Burt LM, Maurer KA, Werner TL, Gaffney DK (2019). The variable impact of positive lymph nodes in cervical cancer: Implications of the new FIGO staging system. Gynecol Oncol, 156(1), 85-92. ()
- Rodriguez AC, Blanchard Z, Maurer KA, Gertz J (2019). Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open Questions. Horm Cancer, 10(2-3), 51-63. ()
- Gaffney DK, Hashibe M, Kepka D, Maurer KA, Werner TL (2018). Too many women are dying from cervix cancer: Problems and solutions. Gynecol Oncol, 151(3), 547-554. ()
- Maurer K, Michener C, Mahdi H, Rose PG (2016). Universal tolerance of nab-paclitaxel for gynecologic malignancies in patients with prior taxane hypersensitivity reactions. J Gynecol Oncol, 28(4), e38. ()
Case Report
- Wei M, Maurer KA, Henry NL (2019). Ovarian remnant syndrome in an aromatase inhibitor-treated patient with BRCA2 mutation following bilateral oophorectomy. Breast J, 25(6), 1254-1256. ()
(
out of
140
reviews
)